20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T15482 | HIF-2α-IN-1 | HIF | |
HIF-2α-IN-1 is a potent HIF-2α inhibitor with IC50 values less than 500 nM. | |||
T11561 | HIF-2α-IN-2 | HIF/HIF Prolyl-Hydroxylase , HIF | |
HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay). | |||
T67831 | HIF-2α agonist 2 | HIF/HIF Prolyl-Hydroxylase , HIF | |
HIF-2α agonist 2 is an HIF-2α agonist with an EC50 value of 1.68 μM for HIF-2α. HIF-2α agonist 2 can promote the stability of the ARNT A/B ring in the 3z structure of HIF-2a-ARNT complex without cytotoxicity to 786-o-Reh... | |||
T50099 | HIF-2α-IN-4 | Others , HIF/HIF Prolyl-Hydroxylase | |
HIF-2a translation inhibitor is a compound used as a molecular building block. | |||
T11562 | HIF-2α-IN-3 | HIF | |
HIF-2α-IN-3 is an allosteric inhibitor of HIF-2α (IC50: 0.4 μM; KD: 1.1 μM) with anticancer activity. | |||
T36711 | FM19G11 | FM19G11,HIF-1alpha/2alpha Inhibitor | HIF |
FM19G11 is an inhibitor of hypoxia inducible factor (HIF) α-subunit (IC50 = 80 nM in hypoxia induced luciferase assay). | |||
T29797 | AKB-6899 | AKB6899 | VEGFR , HIF/HIF Prolyl-Hydroxylase , HIF |
AKB-6899 is an inhibitor of prolyl hydroxylase domain 3 (PHD3) and increases the soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated macrophages. AKB-6899 leads to stabilization of HIF-2α which in... | |||
T61367 | HIF-2α-IN-6 | ||
HIF-2α-IN-6 (117) is a HIF-2α inhibitor [1]. | |||
T72997 | HIF-2α-IN-7 | ||
HIF-2α-IN-7 is a hypoxia inducible factor 2α (HIF-2α) inhibitor. HIF-2α-IN-7 can inhibit HIF-2α with an EC 50 value of 6 nM. HIF-2α-IN-7 can be used for the research of various types of diseases including cancer , liver ... | |||
T61614 | HIF-2α-IN-5 | ||
HIF-2α-IN-5 is a potent HIF-2α inhibitor with an IC 50 of < 50 nM [1]. | |||
T78937 | HIF-2α-IN-9 | HIF/HIF Prolyl-Hydroxylase | |
HIF-2α-IN-9 (compound 35r) serves as an HIF-2α inhibitor, effectively suppressing VEGF-A with an IC50 of 305 nM, and modulating growth-promoting genes within tumor cells while reactivating macrophage-mediated tumor immun... | |||
T61102 | HIF-1/2α-IN-2 | ||
HIF-1/2α-IN-2 is a potent inhibitor of HIF-1/2α, which effectively reduces the levels of HIF-1/2α. This compound elicits an iron starvation response by specifically targeting ISCA2, a key protein involved in Iron Sulfur ... | |||
T0692 | Allopurinol | Zyloric,Zyloprim,Lopurin | ROS , Xanthine Oxidase |
Allopurinol (Zyloric) is a Xanthine Oxidase Inhibitor. The mechanism of action of allopurinol is as a Xanthine Oxidase Inhibitor. | |||
T61442 | HIF-1/2α-IN-1 | ||
HIF-1/2α-IN-1, an orally active compound, functions as an inhibitor of HIF-2α. Its inhibitory effect on HIF-2α activity is significant, with an IC 50 value of 0.92 μM. Furthermore, HIF-1/2α-IN-1 has the ability to decrea... | |||
T6376 | Allopurinol Sodium | Allopurinol sodium salt,Sodium allopurinol | ROS |
Allopurinol Sodium is a xanthine oxidase inhibitor with an IC50 of 7.82±0.12 μM. | |||
T17009 | TC-S 7009 | HIF | |
TC-S 7009 is a potent and selective HIF-2α inhibitor (Kd: 81 nM). The affinity of TC-S 7009 to HIF-2α was higher than that of HIF-1α (Kd >> 5μM). TC-S 7009 disrupts HIF-2α heterodimerization, reduces HIF-2α target gene e... | |||
T7802 | M1001 | HIF/HIF Prolyl-Hydroxylase , HIF | |
M1001 is a HIF-2α agonist. | |||
T7848 | PT-2385 | HIF/HIF Prolyl-Hydroxylase , HIF | |
PT-2385 is a selective HIF-2α inhibitor (Kd<50 nM). | |||
T12675L | PT2399 | HIF/HIF Prolyl-Hydroxylase , HIF | |
PT2399 shows effective antitumor activity in vivo. PT2399 is an effective and selective HIF-2α antagonist, which directly binds to the HIF-2α PAS B domain (IC50: 6 nM). | |||
T16679 | Belzutifan | PT2977,MK-6482 | HIF |
Belzutifan (MK-6482) is a potential treatment for clear cell renal cell carcinoma (ccRCC). Belzutifan is an orally active and selective HIF-2α inhibitor (IC50: 9 nM). Belzutifan , as a second-generation HIF-2α inhibitor,... |